These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor. Sanjo H; Zajonc DM; Braden R; Norris PS; Ware CF J Biol Chem; 2010 May; 285(22):17148-55. PubMed ID: 20348096 [TBL] [Abstract][Full Text] [Related]
4. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products. Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421 [TBL] [Abstract][Full Text] [Related]
5. Early embryonic lethality caused by targeted disruption of the TRAF-interacting protein (TRIP) gene. Park ES; Choi S; Kim JM; Jeong Y; Choe J; Park CS; Choi Y; Rho J Biochem Biophys Res Commun; 2007 Nov; 363(4):971-7. PubMed ID: 17927961 [TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor. Regamey A; Hohl D; Liu JW; Roger T; Kogerman P; Toftgard R; Huber M J Exp Med; 2003 Dec; 198(12):1959-64. PubMed ID: 14676304 [TBL] [Abstract][Full Text] [Related]
7. TRIP/NOPO E3 ubiquitin ligase promotes ubiquitylation of DNA polymerase η. Wallace HA; Merkle JA; Yu MC; Berg TG; Lee E; Bosco G; Lee LA Development; 2014 Mar; 141(6):1332-41. PubMed ID: 24553286 [TBL] [Abstract][Full Text] [Related]
8. The TRAF-interacting protein (TRIP) is a regulator of keratinocyte proliferation. Almeida S; Ryser S; Obarzanek-Fojt M; Hohl D; Huber M J Invest Dermatol; 2011 Feb; 131(2):349-57. PubMed ID: 21068752 [TBL] [Abstract][Full Text] [Related]
9. The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. Lamothe B; Campos AD; Webster WK; Gopinathan A; Hur L; Darnay BG J Biol Chem; 2008 Sep; 283(36):24871-80. PubMed ID: 18617513 [TBL] [Abstract][Full Text] [Related]
10. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Li X; Yang Y; Ashwell JD Nature; 2002 Mar; 416(6878):345-7. PubMed ID: 11907583 [TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro recruitment of an IkappaBalpha-ubiquitin ligase to IkappaBalpha phosphorylated by IKK, leading to ubiquitination. Suzuki H; Chiba T; Kobayashi M; Takeuchi M; Furuichi K; Tanaka K Biochem Biophys Res Commun; 1999 Mar; 256(1):121-6. PubMed ID: 10066434 [TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation. Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232 [TBL] [Abstract][Full Text] [Related]
13. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. Pomerantz JL; Baltimore D EMBO J; 1999 Dec; 18(23):6694-704. PubMed ID: 10581243 [TBL] [Abstract][Full Text] [Related]
14. The role of the TRAF-interacting protein in proliferation and differentiation. Chapard C; Hohl D; Huber M Exp Dermatol; 2012 May; 21(5):321-6. PubMed ID: 22509826 [TBL] [Abstract][Full Text] [Related]
15. Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase. Takeuchi J; Hirota K; Itoh T; Shinkura R; Kitada K; Yodoi J; Namba T; Fukuda K Antioxid Redox Signal; 2000; 2(1):83-92. PubMed ID: 11232604 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation. Reiley W; Zhang M; Wu X; Granger E; Sun SC Mol Cell Biol; 2005 May; 25(10):3886-95. PubMed ID: 15870263 [TBL] [Abstract][Full Text] [Related]
17. Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation. Li S; Lu K; Wang J; An L; Yang G; Chen H; Cui Y; Yin X; Xie P; Xing G; He F; Zhang L Mol Cell Biochem; 2010 May; 338(1-2):11-7. PubMed ID: 19937093 [TBL] [Abstract][Full Text] [Related]
18. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation. Sung B; Pandey MK; Aggarwal BB Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141 [TBL] [Abstract][Full Text] [Related]
19. Regulation of autophagy by E3 ubiquitin ligase RNF216 through BECN1 ubiquitination. Xu C; Feng K; Zhao X; Huang S; Cheng Y; Qian L; Wang Y; Sun H; Jin M; Chuang TH; Zhang Y Autophagy; 2014; 10(12):2239-50. PubMed ID: 25484083 [TBL] [Abstract][Full Text] [Related]
20. Isodeoxyelephantopin, a novel sesquiterpene lactone, potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis through suppression of nuclear factor-kappaB (nf-kappaB) activation and nf-kappaB-regulated gene expression. Ichikawa H; Nair MS; Takada Y; Sheeja DB; Kumar MA; Oommen OV; Aggarwal BB Clin Cancer Res; 2006 Oct; 12(19):5910-8. PubMed ID: 17021000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]